Message from the Chair

Message from the Chair of the 32nd JSSX Annual Meeting

Mikihisa Takano, Ph.D.
Chair of the 32nd JSSX Annual Meeting

It is my great pleasure and honor to hold the 32nd JSSX (Japanese Society for the Study of Xenobiotics) Annual Meeting at Tower Hall Funabori in Tokyo, from November 29th to December 1st, 2017.

In January of 2016, JSSX was reborn as a general incorporated association. Needless to say, it is very important to further develop the research in the field of Drug Metabolism and Pharmacokinetics (DMPK). At the same time, it is also important to consider the possible contribution of JSSX to the society, as an academic organization as well as a general incorporated association. The overall theme of this meeting is "JSSX as a leading society for drug development and clinical pharmacotherapy".

I believe that the importance of the research on DMPK will not change in the future. So far, the research concerning the main factors controlling pharmacokinetics and drug-drug interaction such as drug transporters and drug metabolizing enzymes has greatly contributed to the drug discovery and development as well as clinical pharmacotherapy. More recently, research fields such as cell and oligonucleotide therapies, quantitative systems pharmacology (QSP), imaging, biomarker, and metabolomics are rapidly expanding and developing. Considering these research trends, the Organizing Committee of this annual meeting will make efforts to prepare the programs including distinguished lectures by Prof. Ulrich M. Zanger (Germany) and Prof. Stephen H. Wright (U.S.A.), DIS symposiums, Japan (JSSX)-Korea (KSAP) joint symposium, predoctoral student symposium, and basic course of PK, which will be interesting for all the participants. Also, I expect that this meeting will facilitate the interchange of personnel, especially among young scientists, in addition to the exchange of scientific knowledge.

Finally, I hope this meeting will be meaningful for all the participants through the presentation and active discussion on the recent progress in the study of DMPK. Please join and enjoy 32nd JSSX Annual Meeting.

Mikihisa Takano, Ph.D.